Evidence map›Paper›PMID 31206646›Full record

ArticleCancer2019

Glioma incidence and survival variations by county-level socioeconomic measures.

David J Cote, Quinn T Ostrom, Haley Gittleman, Kelsey R Duncan, Travis S CreveCoeur, Carol Kruchko, Timothy R Smith, Meir J Stampfer, Jill S Barnholtz-Sloan

Open access · bronzeAbstract read
In one paragraph

Article in Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 2 syntheses or guidelines pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Environmental Hazards and Glial Brain Tumors: Association or Causation?International journal of molecular sciences · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

David J CoteChanning Division of Network Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.ORCID 0000-0001-5419-1517
Quinn T OstromCentral Brain Tumor Registry of the United States, Hinsdale, Illinois.ORCID 0000-0003-3469-7558
Haley GittlemanCentral Brain Tumor Registry of the United States, Hinsdale, Illinois.
Kelsey R DuncanDepartment of Neurology, Case Western Reserve University, Cleveland, Ohio.
Travis S CreveCoeurDepartment of Neurosurgery, Washington University in St. Louis, St. Louis, Missouri.
Carol KruchkoCentral Brain Tumor Registry of the United States, Hinsdale, Illinois.
Timothy R SmithDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
Meir J StampferChanning Division of Network Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.
Jill S Barnholtz-SloanCentral Brain Tumor Registry of the United States, Hinsdale, Illinois.ORCID 0000-0001-6190-9304
Central Brain Tumor Registry of the United States · USBrigham and Women's Hospital · USBaylor College of Medicine · USCase Western Reserve University · USHarvard University · USWashington University in St. Louis · US

Funding

Training Program in Cancer EpidemiologyT32CA009001 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI A. Heather Eliassen, Meir Stampfer · 1985 to 2026
$17.3M
Cancer Prevention and Research Institute of Texas RP160097TCDC HHS 2016-M-9030NCI NIH HHS T32 CA009001
6 · The paper itself

Abstract

backgroundMultiple studies have reported higher rates of glioma in areas with higher socioeconomic status (SES) but to the authors' knowledge have not stratified by other factors, including race/ethnicity or urban versus rural location.

methodsThe authors identified the average annual age-adjusted incidence rates and calculated hazard ratios for death for gliomas of various subtypes, stratified by a county-level index for SES, race/ethnicity, US region, and rural versus urban status.

resultsRates of glioma were highest in counties with higher SES (rate ratio, 1.18; 95% CI, 1.15-1.22 comparing the highest with the lowest quintiles [P < .001]). Stratified by race/ethnicity, higher rates in high SES counties persisted for white non-Hispanic individuals. Stratified by rural versus urban status, differences in incidence by SES were more pronounced among urban counties. Survival was higher for residents of high SES counties after adjustment for age and extent of surgical resection (hazard ratio, 0.82; 95% CI, 0.76-0.87 comparing the highest with the lowest quintile of SES [P < .001]). Survival was higher among white Hispanic, black, and Asian/Pacific Islander individuals compared with white non-Hispanic individuals, after adjustment for age, SES, and extent of surgical resection, and when restricted to those individuals with glioblastoma who received radiation and chemotherapy.

conclusionsThe incidence of glioma was higher in US counties of high compared with low SES. These differences were most pronounced among white non-Hispanic individuals and white Hispanic individuals residing in urban areas. Better survival was observed in high SES counties, even when adjusting for extent of surgical resection, and when restricted to those who received radiation and chemotherapy for glioblastoma. Differences in incidence and survival were associated with SES and race, rather than rural versus urban status.

Indexed as

Health Status DisparitiesSocioeconomic FactorsAdultAsianBlack or African AmericanBrainBrain NeoplasmsChemoradiotherapy, AdjuvantDatasets as TopicFemaleGliomaHispanic or LatinoHumansIncidenceMaleNative Hawaiian or Pacific Islanderdisparityglioblastomagliomaincidencesocioeconomicsurvival

Identifiers

PMID31206646
PMCPMC6744292
OpenAlexW2952126206

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.